Karyopharm Therapeutics Inc. Debt Instrument, Convertible, Carrying Amount of Equity Component
Karyopharm Therapeutics Inc. (KPTI) had Debt Instrument, Convertible, Carrying Amount of Equity Component of $67.90 million as of 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent · last filed 2021-02-24
- 2020-12-31: Debt Instrument, Convertible, Carrying Amount of Equity Component $67.90M.
- 2020-09-30: Debt Instrument, Convertible, Carrying Amount of Equity Component $67.90M.
- 2020-06-30: Debt Instrument, Convertible, Carrying Amount of Equity Component $67.90M.
- 2020-03-31: Debt Instrument, Convertible, Carrying Amount of Equity Component $67.90M.
| Period end | Debt Instrument, Convertible, Carrying Amount of Equity Component |
|---|---|
| 2020-12-31 | $67.90M 10-K · filed 2021-02-24 |
| 2020-09-30 | $67.90M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $67.90M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $67.90M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $67.90M 10-K · filed 2020-02-26 |
| 2019-09-30 | $67.90M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $67.85M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $67.85M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $67.85M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |